Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Goto

Showing results (101-110 of 265) with videos related to

Pageof 27
Sort By:
Stroke|January 12, 2013
Carotid atherosclerosis and risk of subsequent coronary event in outpatients with atherothrombosisGaia Sirimarco, Pierre Amarenco, Julien Labreuche, et al.
Journal of the American Heart Association|September 30, 2016
Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) RegistryAlon Eisen, Deepak L Bhatt, P Gabriel Steg, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|December 15, 2017
Drug Class, Renal Elimination, and Outcomes of Direct Oral Anticoagulants in Asian Patients: A Meta-AnalysisKang-Ling Wang, Chun-Chih Chiu, Robert P Giugliano, et al.
European Journal of Preventive Cardiology|May 1, 2014
Interaction between diabetes and a high ankle-brachial index on mortality riskLouis Potier, Ronan Roussel, Julien Labreuche, et al.
Atherosclerosis|January 21, 2021
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?Dan Atar, J Wouter Jukema, Bart Molemans, et al.
European Heart Journal|March 12, 2014
Renin-angiotensin system antagonists and clinical outcomes in stable coronary artery disease without heart failureEmmanuel Sorbets, Julien Labreuche, Tabassome Simon, et al.
Circulation|January 2, 2013
A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery diseaseGregory Ducrocq, Pierre Amarenco, Julien Labreuche, et al.
The American Journal of Medicine|June 27, 2013
Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosisDharam J Kumbhani, Ph Gabriel Steg, Christopher P Cannon, et al.
Plos One|April 27, 2017
In vitro and in vivo antivirus activity of an anti-programmed death-ligand 1 (PD-L1) rat-bovine chimeric antibody against bovine leukemia virus infectionAsami Nishimori, Satoru Konnai, Tomohiro Okagawa, et al.
The American Journal of Cardiology|February 16, 2016
Outcomes in Stable Patients With Previous Atherothrombotic Events Receiving Vorapaxar Who Experience a New Acute Coronary Event (from TRA2°P-TIMI 50)David D Berg, Marc P Bonaca, Eugene Braunwald, et al.
Pageof 27

Showing results (101-110 of 265) with videos related to

Sort By:
Pageof 27
Stroke|January 12, 2013
Carotid atherosclerosis and risk of subsequent coronary event in outpatients with atherothrombosisGaia Sirimarco, Pierre Amarenco, Julien Labreuche, et al.
Journal of the American Heart Association|September 30, 2016
Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) RegistryAlon Eisen, Deepak L Bhatt, P Gabriel Steg, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|December 15, 2017
Drug Class, Renal Elimination, and Outcomes of Direct Oral Anticoagulants in Asian Patients: A Meta-AnalysisKang-Ling Wang, Chun-Chih Chiu, Robert P Giugliano, et al.
European Journal of Preventive Cardiology|May 1, 2014
Interaction between diabetes and a high ankle-brachial index on mortality riskLouis Potier, Ronan Roussel, Julien Labreuche, et al.
Atherosclerosis|January 21, 2021
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?Dan Atar, J Wouter Jukema, Bart Molemans, et al.
European Heart Journal|March 12, 2014
Renin-angiotensin system antagonists and clinical outcomes in stable coronary artery disease without heart failureEmmanuel Sorbets, Julien Labreuche, Tabassome Simon, et al.
Circulation|January 2, 2013
A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery diseaseGregory Ducrocq, Pierre Amarenco, Julien Labreuche, et al.
The American Journal of Medicine|June 27, 2013
Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosisDharam J Kumbhani, Ph Gabriel Steg, Christopher P Cannon, et al.
Plos One|April 27, 2017
In vitro and in vivo antivirus activity of an anti-programmed death-ligand 1 (PD-L1) rat-bovine chimeric antibody against bovine leukemia virus infectionAsami Nishimori, Satoru Konnai, Tomohiro Okagawa, et al.
The American Journal of Cardiology|February 16, 2016
Outcomes in Stable Patients With Previous Atherothrombotic Events Receiving Vorapaxar Who Experience a New Acute Coronary Event (from TRA2°P-TIMI 50)David D Berg, Marc P Bonaca, Eugene Braunwald, et al.
Pageof 27